secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-04-19T23:59:59+00:00
Accession:  0001193125-23-105591
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q1 EPS $8.30 GAAP, $9.46 adjusted; raises full-year guidance
----------------------------------------------------------------------------

- GAAP net income $8.30/share; adjusted net income $9.46/share, beating expectations.
- Operating revenue $41.9B, up 10.6% YoY; operating gain $2.8B, up 16.6% YoY.
- Medical enrollment 48.1M, up 1.3M YoY driven by Medicaid, Medicare Advantage, ACA.
- Raised 2023 outlook: GAAP EPS >$29.50, adjusted EPS >$32.70.
- Q2 dividend $1.48/share declared; payable June 23 to holders of record June 9.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/0001193125-23-105591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/d490195d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-105591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer